Skip to content

LivaNova LIVN Net debt / EBITDA

Net debt / EBITDA at other companies

Abbott logo
AbbottABT
2.5×+1.9×
Haemonetics logo
HaemoneticsHAE
2.4×-0.7×
Medtronic logo
MedtronicMDT
2.9×-0.2×
ResMed logo
ResMedRMD
-0.3×-0.3×
Boston Scientific logo
Boston ScientificBSX
-0.1×-2.9×
Stryker logo
StrykerSYK
1.9×-1.3×

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

Based on the most recent quarter.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's net debt / EBITDA?
LivaNova (LIVN) reported net debt / EBITDA of -0.8× in Q1 2026.
How has LivaNova's net debt / EBITDA changed year-over-year?
LivaNova's net debt / EBITDA decreased by 166.8% year-over-year, from -0.3× to -0.8×.
What is the long-term trend for LivaNova's net debt / EBITDA?
Over 2 years (2021 to 2025), LivaNova's net debt / EBITDA has grown at a -47.2% compound annual growth rate (CAGR), from 3× to -0.8×.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.